Skip to main content

Peptidergic Activation of Muscarinic M1 Inhibition in the Canine Small Intestine in Vivo

  • Conference paper
Muscarinic Receptor Subtypes in the GI Tract

Abstract

During the process of evaluating the role of peptides in the control of motility of the canine gastrointestinal tract (Daniel et al. 1983), we commenced the practise of testing the response of all agonists during both quiescence and during regular phasic activity either spontaneous or induced by field stimulation or intraarterial injection of motilin (Fox et al. 1984). This revealed new profoundly inhibitory actions of a number of agents which had previously seemed to have exclusively excitatory actions. These included acetylcholine (Fox et al. 1983 b; Fox et al. 1985), substance P (Fox et al. 1983 a; Fox and Daniel 1985), bombesin/gastrin-releasing peptide (GRP) (Fox and McDonald 1984), and the putative M1 muscarinic receptor agonist McNeil A 343 (Fox et al. 1985). Pharmacological studies have suggested that these agonists produce inhibition by activating directly (acetylcholine and McNeil A 343) or indirectly (substance P and GRP) a muscarinic M1 inhibitory receptor located in the myenteric plexus. The evidence for this hypothesis is summarized below.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Daniel EE, Gandu T, Damoto T, Oki M, Yanaihara N (1982) The effects of substance P and met5 enkephalin in dog ileum. Can J Physiol Pharmacol 60: 830–840.

    Article  PubMed  CAS  Google Scholar 

  • Daniel EE, Fox JET, Oki M, Donoto T, Sakai Y, Yanaihara W, Tack NS (1983) Study of peptides in control of motility. In: Chey WY (ed) Functional disorders of the digestive tract. Raven, New York, pp 103–112.

    Google Scholar 

  • Daniel EE, Costa M, Furness JB, Keast JR (1985) Peptide neurons in the canine small intestine. J Comp Neurol (to be published).

    Google Scholar 

  • Fox JET, Daniel EE (1985) Substance P: a potent inhibitor of the canine small intestine in vivo. Am J Physiol (to be published).

    Google Scholar 

  • Fox JET, McDonald TJ (1984) Motor effects of gastrin releasing peptide (GRP) and bombesin in the canine stomach and small intestine. Life Sci 35: 1667–1673.

    Article  PubMed  CAS  Google Scholar 

  • Fox JET, Daniel EE, Jury J (1983a) Substance P (SP): a participant in the inhibitory “brake” mechanism of canine small intestine. In: Skrabenek P, Powell D (eds) Substance P. Dublin 1983. Boole, Dublin, pp 105–106.

    Google Scholar 

  • Fox JET, Daniel EE, McDonald TJ, Jury J, Robotham KH (1983b) Evidence for a muscarinic brake activated by peptides in the canine small intestine. In: Roman C (ed) Gastrointestinal motility. MTP Press, Lancaster, pp 327–333.

    Google Scholar 

  • Fox JET, Daniel EE, Jury J, Robotham H (1984) The mechanism of motilin excitation of the canine small intestine. Life Sci 34: 1001–1006.

    Article  PubMed  CAS  Google Scholar 

  • Fox JET, Daniel EE, Jury J, Robotham H (1985) Muscarinic inhibition of canine small intestinal motility in vivo. Am J Physiol (to be published).

    Google Scholar 

  • Gilbert R, Rattan S, Goyal RK (1984) Pharmacologic identification, activation, and antagonism of two muscarinic receptor subtypes in the lower esophageal sphincter. J Pharmacol Exp Ther 230: 284–291.

    PubMed  CAS  Google Scholar 

  • Hammer R, Giachetti A (1982) Muscarinic receptor subtypes M1 and M2 biochemical and functional choracleugation. Life Sci 31: 2991–2998.

    Article  PubMed  CAS  Google Scholar 

  • Mayer EA, Elashoff J, Walsh JH (1982) Characterization of bombesin effects on canine gastric muscle. Am J Physiol 243: G 141–G 147.

    CAS  Google Scholar 

  • Sakai Y, Daniel EE, Jury J, Fox JET (1984) Neurotensin inhibition of canine intestinal motility in vivo via α-adrenoceptors. Can J Physiol Pharmacol 62: 403–411.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fox, J.E.T., Daniel, E.E., McDonald, T.J. (1985). Peptidergic Activation of Muscarinic M1 Inhibition in the Canine Small Intestine in Vivo. In: Lux, G., Daniel, E.E. (eds) Muscarinic Receptor Subtypes in the GI Tract. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70668-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70668-4_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70670-7

  • Online ISBN: 978-3-642-70668-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics